Preparing for FDA Inspection and Handling the Consequences 2012
31 May 2012
Webinar
Description
Topics
Discussion on receiving and responding to 483s and warning letters
Preparing for an FDA Inspection
Discussion on what actions the FDA can take over and beyond issuing a 483 or Warning Letter
Who should Attend
Project Managers
Clinical Research managers
Monitors
Clinical Research Associates
Research coordinators
Quality Assurance Professionals
Clinical investigators
Past Events
Preparing for FDA Inspection and Handling the Consequences 2012 - 31 May 2012, Webinar (29152)
Important
Please, check "Preparing for FDA Inspection and Handling the Consequences" official website for possible changes, before making any traveling arrangements
Event Categories
Education: Training
Health & Medicine: Medical laboratories, Medical technology, Pharma
